Zai Lab (ZLAB) Operating Expenses (2020 - 2026)
Zai Lab's (ZLAB) quarterly Operating Expenses came in at $130.7 million in Q1 2026, up 5.24% year-on-year from $124.2 million in Q1 2025, and down 2.98% quarter-over-quarter from $134.7 million in Q4 2025.
Zai Lab (ZLAB) Operating Expenses (2020 - 2026) Analysis & Trends
Zai Lab has disclosed Operating Expenses across 7 years of filings, most recently posting $130.7 million for Q1 2026.
- Operating Expenses for Q1 2026 came in at $130.7 million, up 5.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $505.0 million (down 5.35% YoY), and the FY2025 annual result was $498.5 million, down 6.51% from the prior year.
- Operating Expenses came in at $130.7 million for Q1 2026 at Zai Lab, down from $134.7 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $166.1 million in Q3 2022 to a low of $110.8 million in Q1 2022.
- The 5-year median for Operating Expenses is $130.7 million (2026), against an average of $132.7 million.
- Peak annual rise in Operating Expenses reached 45.5% in 2022, while the deepest fall reached 53.75% in 2022.
- Zai Lab's Operating Expenses stood at $139.0 million in 2022, then advanced by 18.42% to $164.6 million in 2023, then fell by 18.05% to $134.9 million in 2024, then decreased by 0.15% to $134.7 million in 2025, then slipped by 2.98% to $130.7 million in 2026.
- The last three Operating Expenses figures came in at $130.7 million (Q1 2026), $134.7 million (Q4 2025), and $118.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -67.40 Mn |
| 10 | Zai Lab | 20.15 Bn | 20.05 Bn | 61.30 Mn | 130.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 130.66 Mn |
| Dec 31, 2025 | 134.67 Mn |
| Sep 30, 2025 | 118.03 Mn |
| Jun 30, 2025 | 121.65 Mn |
| Mar 31, 2025 | 124.15 Mn |
| Dec 31, 2024 | 134.87 Mn |
| Sep 30, 2024 | 133.20 Mn |
| Jun 30, 2024 | 141.34 Mn |
| Mar 31, 2024 | 123.84 Mn |
| Dec 31, 2023 | 164.57 Mn |
| Sep 30, 2023 | 127.32 Mn |
| Jun 30, 2023 | 144.60 Mn |
| Mar 31, 2023 | 110.98 Mn |
| Dec 31, 2022 | 138.97 Mn |
| Sep 30, 2022 | 166.08 Mn |
| Jun 30, 2022 | 129.49 Mn |
| Mar 31, 2022 | 110.85 Mn |
| Dec 31, 2021 | 241.66 Mn |
| Sep 30, 2021 | 114.15 Mn |
| Jun 30, 2021 | 196.64 Mn |